# Ypsomed opens new production hall in Schwerin, announces further expansion

Ypsomed opened a new production hall (Hall D) at its Schwerin site, investing 22 million CHF. The company also announced a further expansion (Schwerin II) starting January 2025, with a total investment of nearly half a billion Swiss francs, to add 400-500 million pens and autoinjectors annual capacity.

- Type: Expansion
- Announced: 2024-10-17
- Where: Schwerin, Germany
- Value: $24.4M (22.0M CHF)
- Starts operating: 17 Oct 2024
- Status: completed
- Capacity: 100 million autoinjectors per year (Hall D); 400-500 million pens and autoinjectors per year (Schwerin II)
- Products: autoinjectors, pens
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Ypsomed](https://endata.com/companies/9625.md)

## Sources

- [ypsomed.com](https://www.ypsomed.com/en/news-insights/news/press-releases/news-reader-detail-page/ypsomed-opens-new-production-hall-in-schwerin-and-announces-further-expansion), 2024-10-17: "The expansion of our Schwerin site is an important step in our growth strategy, which will enable us to increase our production capacity and expand further in the coming years."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.